David K. Hong
Spero Therapeutics (United States)(US)
Publications by Year
Research Areas
Mycobacterium research and diagnosis, Antifungal resistance and susceptibility, Influenza Virus Research Studies, Fungal Infections and Studies, Bacterial Identification and Susceptibility Testing
Most-Cited Works
- → Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology(2020)1,607 cited
- → Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease(2019)942 cited
- → Molecular Basis of T Cell Inactivation by CTLA-4(1998)685 cited
- → Broad betacoronavirus neutralization by a stem helix–specific human antibody(2021)424 cited
- → TNFα-308A allele in juvenile dermatomyositis: Association with increased production of tumor necrosis factor α, disease duration, and pathologic calcifications(2000)248 cited
- → Liquid biopsy for infectious diseases: sequencing of cell-free plasma to detect pathogen DNA in patients with invasive fungal disease(2018)194 cited
- → Evaluation of Plasma Microbial Cell-Free DNA Sequencing to Predict Bloodstream Infection in Pediatric Patients With Relapsed or Refractory Cancer(2019)128 cited
- → Plasma Microbial Cell-free DNA Next-generation Sequencing in the Diagnosis and Management of Febrile Neutropenia(2021)122 cited
- → Cell‐free DNA next‐generation sequencing successfully detects infectious pathogens in pediatric oncology and hematopoietic stem cell transplant patients at risk for invasive fungal disease(2019)105 cited
- → Liquid Biopsy for Invasive Mold Infections in Hematopoietic Cell Transplant Recipients With Pneumonia Through Next-Generation Sequencing of Microbial Cell-Free DNA in Plasma(2020)102 cited